The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity

NIH added an observational study registration entry to ClinicalTrials.gov documenting a new research protocol examining GPCR-autoantibodies in individuals living with obesity. The study aims to determine whether these autoantibodies are present in people with obesity and whether their levels correlate with obesity severity or associated metabolic diseases such as Type 2 Diabetes Mellitus.

Healthcare research institutions and clinical investigators conducting obesity or metabolic disease research should note this study as part of the broader research landscape. Patients enrolled in the study will undergo observation and biological sample collection. No compliance obligations are created for healthcare providers by this registry entry.